|
Epidemiology and racial differences of prostate cancer clinical states. |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - Myovant Sciences |
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Blue Earth Diagnostics (Inst); Diasorin (Inst); Exact Sciences (Inst); Ferring (Inst); Janssen (Inst); LungLife AI (Inst); MDxHealth (Inst); Merck (Inst); Myriad Genetics (Inst); Pfizer (Inst); Sanofi (Inst) |
|
|
Employment - Merck Sharp & Dohme; Novartis |
Stock and Other Ownership Interests - Advaxis (I); Agenus (I); AVEO (I); Bellicum Pharmaceuticals (I); Bellicum Pharmaceuticals (I); Calithera Biosciences (I); Idera (I); Mannkind; Provectus |
|
|
|
Stock and Other Ownership Interests - Merck |
|
|
No Relationships to Disclose |
|
|
|
Stock and Other Ownership Interests - Merck; Sanofi |
Research Funding - Merck; Merck; Merck; Merck; Sanofi |
Travel, Accommodations, Expenses - Merck; Sanofi |
|
|
Employment - Genomic Health (I) |
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Clovis Oncology; Dendreon; Exact Sciences; Ferring; Janssen Biotech; Merck; Myovant Sciences; Pfizer; Sanofi |
Speakers' Bureau - AstraZeneca; Sanofi |
Research Funding - Bayer (Inst); Diasorin; GenomeDx (Inst); Janssen Biotech (Inst); MDxHealth (Inst); Merck; Myriad Genetics (Inst); OPKO Diagnostics (Inst); Progenika (Inst) |
Travel, Accommodations, Expenses - Sanofi |